Obesity as a Chronic Disease: SA Pushes for Treatment Access
Learn how acknowledging obesity as a chronic disease can transform healthcare approaches and reduce long-term health costs.
Generic Semaglutide in India: Affordable Treatment Options
Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications.
Generic Semaglutide Set to Disrupt Global GLP‑1 Market
Aspen Pharmacare is lining up a generic semaglutide launch in Canada, promising big discounts, and widening GLP-1 access.
GLP-1 Weight Loss Drugs Reshape Obesity Care In South Africa
GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers.
Wegovy Weight-Loss Pill Offers Injectables Alternative
Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.
Obesity Drug Deal: Trump Cuts Prices for Patients
The landmark obesity drug deal announced by Trump aims to make weight management drugs more affordable for millions of patients.
Aspen Boosted by Mounjaro: A New Era in Weight Loss
Aspen shares soar following the approval of Mounjaro for weight loss in South Africa. Discover the impact on obesity management.
Cheaper Weight-Loss Drugs for Global Health Needs
… Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log in here...
The Obesity Gene That Could Change Treatments
In a significant stride towards understanding and combating diet-related obesity, researchers at the University of Pretoria (UP) have identified a gene that could be central to how our bodies accumulate fat. The discovery offers a glimmer of hope for the millions of South Africans struggling with their weight. It could revolutionise future treatments centred around…...
The Rise in Obesity: Rethinking Our Response
The rise in obesity, especially among the youth, calls for immediate public health strategies. Discover what needs to be done.